SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049909
Filing Date
2024-04-29
Accepted
2024-04-29 16:24:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ntla_defa14a_2024.htm DEFA14A 15345
2 GRAPHIC img232108801_0.jpg GRAPHIC 2253813
3 GRAPHIC img232108801_1.jpg GRAPHIC 1833102
  Complete submission text file 0000950170-24-049909.txt   5645350
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37766 | Film No.: 24891289
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)